A federal courtroom in Oakland is quietly deciding the most important question in the AI industry: whether the business model behind today’s leading labs is even legal. The Musk v Altman trial isn’t just about who controlled OpenAI — it’s about whether any mission‑driven AI lab can ever convert to a for‑profit structure without triggering massive legal risk.

For the past three days, Elon Musk and Sam Altman have been seated about twenty feet apart , watching each other from opposite sides of an aisle while a nine-person jury hears arguments about whether OpenAI, the company that built ChatGPT, was illegally taken from a charity and turned into a for-profit empire.

The headlines have focused on the personalities — Musk calling himself "a fool" on the stand, Altman watching impassively, lawyers shouting over each other, the judge cutting in to keep order. But beneath the courtroom drama, something more important is being decided. The verdict in Oakland will set legal precedent for an industry that did not exist when the relevant laws were written. That precedent will shape how every AI lab can be capitalized in the decade ahead.

Here is what the trial is actually deciding, and why it matters more than the news coverage has explained.

How The Trial Is Structured

The case is Musk v. Altman, filed in August 2024 in U.S. District Court for the Northern District of California. The defendants are OpenAI, Sam Altman, OpenAI President Greg Brockman and Microsoft.

Musk originally filed 26 separate claims. Through a year of pretrial proceedings, that number narrowed to two surviving legal questions:

  1. Breach of charitable trust : Did the roughly $38 million Musk donated to OpenAI between 2015 and 2018 create a legal trust that required the company to remain a nonprofit forever?
  2. Unjust enrichment : Did Altman and Brockman use those donations for purposes that did not align with the original charitable mission, and did they personally benefit from doing so?

Judge Yvonne Gonzalez Rogers split the trial into two phases. The current phase is liability. If the jury finds against any defendant, the trial moves to a remedies phase, which determines damages. Musk's lawyers filed in January that he should receive up to $134 billion in "wrongful gains" — a number large enough to put OpenAI's pending IPO at existential risk if the jury rules against the company.

What The First Three Days Established

Strip away the back-and-forth and three things became clear from this week's testimony.

First, both sides agree the for-profit transition happened. What is in dispute is whether it was lawful. Musk's case is not that OpenAI restructured. His case is that the restructuring violated the charitable mission donors funded.

Second, the timing of Musk’s lawsuit is OpenAI’s strongest defense. Court exhibits showed Musk himself proposed for-profit structures in 2015, directed advisers to register a for-profit entity in 2017 and publicly stated in a 2020 X post that "OpenAI is essentially captured by Microsoft." OpenAI’s lawyers argue Musk knew about the transition for years and only sued when his rival xAI began struggling. Microsoft is using the same timeline as a statute-of-limitations defense.

Third, the financial number Musk built his case around was specific. He testified that his $38 million in donations was used to create what he claimed was an $800 billion for-profit company. That ratio — donor capital to current valuation — is the framing the jury will carry into deliberations. It is also the kind of disparity that creates real legal risk for any nonprofit that converts.

What The Jury Is Actually Deciding

The jury is being asked three specific questions, each with consequences far beyond OpenAI:

  1. Did Musk's donations create a charitable trust that legally bound OpenAI to remain a nonprofit? If yes, every donation to a mission-driven AI lab can potentially be reframed as a legally enforceable trust. That dramatically alters how those organizations can ever restructure.
  2. Did Altman and Brockman personally benefit in a way that constitutes unjust enrichment? This is the question that determines remedies. If yes, the court can claw back equity, force divestiture or impose damages.
  3. Did Microsoft substantially assist a breach of the charitable mission? This question has the broadest implications because it sets a new standard for how strategic investors interact with mission-driven companies.

The first question is the hardest legally. California charitable-trust doctrine has genuine ambiguity about whether a donation creates a perpetual trust without explicit written language. Most legal commentary leans "no," but probably is not certainty.

The second is more about facts than law. Compensation packages and equity stakes will be examined.

The third is the one investors should watch most closely.

Why The Microsoft Question Is The Real Industry Test

Microsoft is not a peripheral defendant. The company has invested more than $13 billion in OpenAI since 2019 and is named on a charge of aiding and abetting a breach of charitable trust.

Microsoft’s defense rests on three arguments: that Musk's lawsuit exceeds the statute of limitations, that Microsoft had no knowledge of any breach and that Musk had Satya Nadella's personal phone number for five years and never raised the concern.

If Microsoft loses, the financial exposure could be in the tens of billions, depending on how the remedies phase calculates damages. The legal precedent matters even more. Every future strategic investment in a mission-driven AI lab would carry new legal risk. The standard of care required for an investor evaluating a partner's governance status would shift overnight.

That is why this trial matters to the AI industry, even for readers who have no opinion on Musk or Altman personally.

What This Means For Every Other AI Lab

The Musk v. Altman verdict will not stay confined to OpenAI. Several other AI organizations will be watching closely.

  • Anthropic was founded as a public benefit corporation rather than a nonprofit, so its structural question is different. But the deeper precedent matters. If a court rules that early donor or investor intent creates legally binding constraints on future restructuring, similar logic could be applied to PBC obligations.
  • xAI , ironically, has gone the opposite direction. Musk’s own AI company merged with SpaceX earlier this year and is for-profit by design. Lower legal exposure, but his testimony in this trial creates a public record about what an AI company should and should not be.
  • Mistral, Cohere and other emerging labs that rely on mission-driven framing to attract talent and early funding now have to evaluate whether their public commitments could later be enforced as charitable trusts.
  • Future AI nonprofits are the group most directly affected. The Musk verdict tells anyone considering founding a nonprofit AI lab whether their early structure can ever be legally unwound. If charitable-trust claims succeed here, the nonprofit AI structure becomes much harder to reverse later — which paradoxically might discourage future labs from starting that way at all.

Musk concluded his testimony Thursday. The trial is expected to run roughly three weeks total. Witnesses still to come include:

  • Greg Brockman, OpenAI president
  • Sam Altman, who will face direct questioning about the conversion
  • Satya Nadella, on Microsoft's investment decisions
  • Stuart Russell, UC Berkeley AI researcher
  • David Schizer, Columbia Law professor and tax scholar

The liability-phase verdict is expected in mid-May. If the jury finds against any defendant, the remedies phase extends proceedings by another two to three weeks.

The single signal investors should watch for is whether the jury concludes OpenAI's for-profit conversion was lawful. If the answer is no, OpenAI faces a governance crisis at exactly the moment it was preparing for an IPO at a reported $850 billion valuation. If the answer is yes, the company gets a decisive legal endorsement and the IPO proceeds with one of the largest legal overhangs in the industry now resolved.

OpenAI is on trial for a corporate structure that did not exist before AI labs needed it, being judged against laws written long before AI labs existed. Whatever the jury decides will define the legal architecture of how the next generation of AI companies gets built. That is the part that should matter to readers, regardless of which side of the aisle they sit on.

The first three days laid the foundation. The next two weeks will determine whether the foundation holds.